L. E. Silberstein

805 total citations
21 papers, 631 citations indexed

About

L. E. Silberstein is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, L. E. Silberstein has authored 21 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Immunology and 4 papers in Genetics. Recurrent topics in L. E. Silberstein's work include Blood groups and transfusion (12 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Immune Cell Function and Interaction (5 papers). L. E. Silberstein is often cited by papers focused on Blood groups and transfusion (12 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Immune Cell Function and Interaction (5 papers). L. E. Silberstein collaborates with scholars based in United States, Netherlands and Israel. L. E. Silberstein's co-authors include Piotr Kraj, David F. Friedman, E. M. Berkman, Freda K. Stevenson, Richard R. Hardy, J Goldman, E C Milner, Sambasiva P. Rao, Annuska M. Glas and Leigh C. Jefferies and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

L. E. Silberstein

21 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. E. Silberstein United States 13 265 221 150 130 115 21 631
P Stammler Switzerland 12 268 1.0× 355 1.6× 92 0.6× 99 0.8× 114 1.0× 20 837
DS Rosenthal United States 13 609 2.3× 160 0.7× 88 0.6× 193 1.5× 294 2.6× 26 979
A. Lubenko United Kingdom 13 507 1.9× 103 0.5× 33 0.2× 164 1.3× 111 1.0× 55 812
Shion Imoto Japan 16 312 1.2× 215 1.0× 20 0.1× 101 0.8× 142 1.2× 49 604
A. E. G. Kr. v. d. Borne Netherlands 13 215 0.8× 203 0.9× 43 0.3× 99 0.8× 82 0.7× 17 603
M. Bérard France 15 225 0.8× 82 0.4× 47 0.3× 65 0.5× 105 0.9× 34 586
A. Stern Switzerland 8 627 2.4× 193 0.9× 35 0.2× 98 0.8× 127 1.1× 17 1.0k
Ulrike Westhoff Germany 11 117 0.4× 336 1.5× 71 0.5× 20 0.2× 42 0.4× 19 517
Hui Zhong United States 15 470 1.8× 224 1.0× 14 0.1× 270 2.1× 102 0.9× 28 766
JE Layton Australia 10 313 1.2× 349 1.6× 29 0.2× 83 0.6× 103 0.9× 14 800

Countries citing papers authored by L. E. Silberstein

Since Specialization
Citations

This map shows the geographic impact of L. E. Silberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. Silberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. Silberstein more than expected).

Fields of papers citing papers by L. E. Silberstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. Silberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. Silberstein. The network helps show where L. E. Silberstein may publish in the future.

Co-authorship network of co-authors of L. E. Silberstein

This figure shows the co-authorship network connecting the top 25 collaborators of L. E. Silberstein. A scholar is included among the top collaborators of L. E. Silberstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. E. Silberstein. L. E. Silberstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kraj, Piotr, Sambasiva P. Rao, Annuska M. Glas, et al.. (1997). The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. The Journal of Immunology. 158(12). 5824–5832. 86 indexed citations
2.
Biggs, David D., Piotr Kraj, J Goldman, et al.. (1995). Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma. Clinical and Diagnostic Laboratory Immunology. 2(1). 44–52. 10 indexed citations
3.
Kraj, Piotr, David F. Friedman, Freda K. Stevenson, & L. E. Silberstein. (1995). Evidence for the overexpression of the VH4-34 ( VH4.21 ) Ig gene segment in the normal adult human peripheral blood B cell repertoire.. The Journal of Immunology. 154(12). 6406–6420. 66 indexed citations
4.
Jefferies, Leigh C., et al.. (1993). Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment.. Journal of Clinical Investigation. 92(6). 2821–2833. 29 indexed citations
5.
Schütte, Mark, Johan H. van Es, L. E. Silberstein, & Ton Logtenberg. (1993). VH4.21-encoded natural autoantibodies with anti-i specificity mirror those associated with cold hemagglutinin disease.. The Journal of Immunology. 151(11). 6569–6576. 33 indexed citations
6.
Lane, Thomas A., KC Anderson, Lawrence T. Goodnough, et al.. (1992). Leukocyte Reduction in Blood Component Therapy. Annals of Internal Medicine. 117(2). 151–162. 99 indexed citations
7.
Friedman, David F., et al.. (1991). Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity. The Journal of Immunology. 147(10). 3623–3631. 9 indexed citations
8.
Friedman, David F., Eunjoo Cho, J Goldman, et al.. (1991). The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma.. The Journal of Experimental Medicine. 174(3). 525–537. 76 indexed citations
9.
Andrzejewski, Chester, et al.. (1991). Heterogeneity of human red cell autoantibodies assessed by isoelectric focusing. Transfusion. 31(3). 236–244. 4 indexed citations
10.
Dan‐Goor, Mary, et al.. (1990). Localization of epitopes and functional effects of two novel monoclonal antibodies against skeletal muscle myosin. Journal of Muscle Research and Cell Motility. 11(3). 216–226. 38 indexed citations
11.
Andrzejewski, Chester, et al.. (1989). Production of human warm‐reacting red cell monoclonal autoantibodies by Epstein‐Barr virus transformation. Transfusion. 29(3). 196–200. 6 indexed citations
12.
Silberstein, L. E.. (1989). Strategies for the review of transfusion practices. JAMA. 262(14). 1993–1997. 12 indexed citations
13.
Andrzejewski, Chester, Elyanne Gault, Moya Briggs, & L. E. Silberstein. (1988). Benefit of a 37°C extracorporeal circuit in plasma exchange therapy for selected cases with cold agglutinin disease. Journal of Clinical Apheresis. 4(1). 13–17. 10 indexed citations
14.
Silberstein, L. E., Janet L. Abrahm, & S.J. Shattil. (1987). The efficacy of intensive plasma exchange in acquired von Willebrand's disease. Transfusion. 27(3). 234–237. 28 indexed citations
15.
Silberstein, L. E., et al.. (1987). Cold Hemagglutinin Disease Associated with IgG Cold-Reactive Antibody. Annals of Internal Medicine. 106(2). 238–242. 32 indexed citations
16.
Silberstein, L. E. & Leslie M. Shaw. (1986). Effect of Plasma Exchange on Phenytoin Plasma Concentration. Therapeutic Drug Monitoring. 8(2). 172–176. 8 indexed citations
17.
Silberstein, L. E., Sonya Naryshkin, John J. Haddad, & Jerome F. Strauss. (1986). Calcium homeostasis during therapeutic plasma exchange. Transfusion. 26(2). 151–155. 29 indexed citations
18.
Sherman, Lori, L. E. Silberstein, & E. M. Berkman. (1984). Altered blood group expression in a patient with congenital rubella infection. Transfusion. 24(3). 267–269. 2 indexed citations
19.
Silberstein, L. E., E. M. Berkman, & Barry L. Fanburg. (1983). Angiotensin-1-Converting Enzyme (ACE) Activity in Human Serum following Plasma Exchange. Experimental Biology and Medicine. 173(2). 222–226. 5 indexed citations
20.
Silberstein, L. E. & E. M. Berkman. (1983). Plasma exchange in autoimmune hemolytic anemia (AIHA). Journal of Clinical Apheresis. 1(4). 238–242. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Stammler Breakdown of academic impact, for papers by DS Rosenthal Breakdown of academic impact, for papers by A. Lubenko Breakdown of academic impact, for papers by Shion Imoto Breakdown of academic impact, for papers by A. E. G. Kr. v. d. Borne Breakdown of academic impact, for papers by M. Bérard Breakdown of academic impact, for papers by A. Stern Breakdown of academic impact, for papers by Ulrike Westhoff Breakdown of academic impact, for papers by Hui Zhong Breakdown of academic impact, for papers by JE Layton
Rankless by CCL
2026